Avalo Therapeutics, Inc. (AVTX) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 40 days, typically, give or take 20 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 5, 2026before open 36 8-K
Q2 FY2026Thu, Aug 6, 2026before open 37 8-K
Q1 FY2026Wed, May 13, 2026before open 43 8-K
Q4 FY2025Mon, Mar 23, 2026before open 82 8-K
Q3 FY2025Thu, Nov 6, 2025before open 37 8-K
Q2 FY2025Thu, Aug 7, 2025before open 38 8-K
Q1 FY2025Mon, May 12, 2025before open 42 8-K
Q4 FY2024Thu, Mar 20, 2025before open 79 8-K

What they guided beta

Q3 FY2026 "Cash, cash equivalents and investments of $462.8 million as of September 30, 2026, expected to fund operations into 2029 WAYNE, Pa., Nov. 5, 2026 – Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company focused on developing therapies targeting the IL-1β pathway for immune-mediated inflammatory diseases, today reported financial results for the third quarter of 2026 and provided a business update." exhibit
Q3 FY2026 "Avalo expects feedback from the U.S. Food and Drug Administration on its proposed development plan by year-end 2026 and plans to initiate the Phase 3 program in the first half of 2027." exhibit
Q3 FY2026 "Avalo’s current cash, cash equivalents, and investments are expected to fund operations into 2029." exhibit
Q3 FY2026 "These increases were partially offset by lower clinical expenses as LOTUS trial and related activities decreased following the topline data readout in May 2026." exhibit
Q2 FY2026 "Cash, cash equivalents and investments of $472.2 million as of June 30, 2026, expected to provide runway into 2029 WAYNE, PA., August 6, 2026 — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced business updates and financial results for the second quarter of 2026." exhibit
Q2 FY2026 "The Company expects to submit an Investigational New Drug (IND) application in the first half of 2027." exhibit
Q2 FY2026 "Avalo’s current cash, cash equivalents, and investments are expected to fund operations into 2029." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AVTX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AVTX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

AVTX earnings date badge

HTML

<a href="https://veritasdata.dev/company/AVTX/"><img src="https://veritasdata.dev/embed/AVTX.svg" alt="AVTX earnings date" width="240" height="56"></a>

Markdown

[![AVTX earnings date](https://veritasdata.dev/embed/AVTX.svg)](https://veritasdata.dev/company/AVTX/)

Script

<script async src="https://veritasdata.dev/embed/AVTX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AVTX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.